| 英文名称 |
中文名称 |
CAS |
|
Heteroclitin C
|
|
140460-42-0 |
|
Kansuiphorin C；KPC
|
|
133898-77-8 |
|
Kushenol M
|
|
101236-51-5 |
|
Methyl 4-caffeoylquinate
|
|
123372-74-7 |
|
Methyl salvionolate A
|
|
1015171-69-3 |
|
Notoginsenoside T5
|
|
769932-34-5 |
|
Phyltetralin
|
|
123048-17-9 |
|
Platycoside M1
|
|
917482-67-8 |
|
Sanggenone K
|
|
86450-77-3 |
|
Sargentol
|
|
623928-18-7 |
|
Monnieriside G
|
|
1401799-34-5 |
|
Tegatrabetan；BC2059
|
|
1227637-23-1 |
|
Multi-kinase inhibitor 1；Multi-kinase inhibitor I
|
|
778274-97-8 |
|
JNJ-42041935；HIF-PHD Inhibitor II
|
|
1193383-09-3 |
|
Poricoic acid AM
|
|
151200-92-9 |
|
CC-115；CC115;CC 115
|
|
1228013-15-7 |
|
Givinostat hydrochloride；ITF2357;ITF-2357;ITF2357 hydrochloride;ITF2357 HCl;Givinostat HCl;Givinostat HCl. gavinostat,;ITF 2357
|
|
199657-29-9 |
|
Monomelittoside；Danmelittoside
|
|
20633-72-1 |
|
PT-2385
|
|
1672665-49-4 |
|
Tos-Gly-Pro-Arg-ANBA-IPA acetate；tos-GPR-ANBA-IPA acetate
|
|
2070009-46-8 |
|
Yoda 1
|
|
448947-81-7 |
|
MCB-613；MCB 613;MCB613
|
|
1162656-22-5 |
|
Oxyresveratrol 3'-O-β-D-glucopyranoside；Oxyresveratrol 3'-O-beta-D-glucopyranoside
|
|
144525-40-6 |
|
LLY-507；LLY 507;LLY507
|
|
1793053-37-8 |
|
Acridan-9-carboxylic acid, 10-methyl-, 2-(diethylamino)ethyl ester, hydrochloride
|
|
69781-84-6 |
|
Glycylhydroxyprolylproline；Tripeptide-6
|
|
22028-82-6 |
|
Olodaterol hydrochloride；BI 1744 hydrochloride;BI-1744 HCl
|
|
869477-96-3 |
|
ETC-159；ETC159;ETC-1922159;ETC 159
|
|
1638250-96-0 |
|
3,4,5'-Trimethoxy-3',4'-methylenedioxy-7,9':7',9-diepoxylignan
|
|
873867-94-8 |
|
4E-Deacetylchromolaenide 4'-O-acetate
|
|
104736-09-6 |
|
Eupalinolide I
|
|
1402067-84-8 |
|
Isolupalbigenin
|
|
162616-70-8 |
|
Sulfidefluor-7 AM
|
|
1416872-50-8 |
|
LJH685
|
|
1627710-50-2 |
|
AMG9810
|
|
545395-94-6 |
|
1-Phenylpropane-1,2-dione；Acetyl benzoyl;1-Phenyl-1,2-propanedione
|
|
579-07-7 |
|
STING agonist-1；G10
|
|
702662-50-8 |
|
C-DIM12
|
|
178946-89-9 |
|
Apcin
|
|
300815-04-7 |
|
G244-LM
|
|
1563007-08-8 |
|
Sacubitril sodium；AHU-377;LCZ696;AHU 377;AHU377
|
|
149690-05-1 |
|
Pridopidine hydrochloride；Pridopidine HCl;FR310826;ASP-2314 hydrochloride;ASP2314 HCl
|
|
882737-42-0 |
|
Hecogenin；Hocogenin
|
|
467-55-0 |
|
3-O-Acetyl-16α-hydroxytrametenolic acid；3-O-Acetyl-16 alpha-hydroxytrametenolic acid
|
|
168293-13-8 |
|
Apratoxin B
|
|
444885-29-4 |
|
GSK3326595；EPZ015938
|
|
1616392-22-3 |
|
Selonsertib；GS-4997
|
|
1448428-04-3 |
|
Orexin 2 Receptor Agonist；OX2R
|
|
1796565-52-0 |
|
ML264；CID-51003603
|
|
1550008-55-3 |
|
GSK481；GSK'481
|
|
1622849-58-4 |
|
SR-3029；SR3029;SR 3029
|
|
1454585-06-8 |
|
SU5201；NSC 247030
|
|
114727-43-4 |
|
Macozinone；PBTZ169
|
|
1377239-83-2 |
|
Sitravatinib；MG516;MGCD516
|
|
1123837-84-2 |
|
FITM
|
|
932737-65-0 |
|
A-794278
|
|
869802-57-3 |
|
MSC 2032964A；MSC-2032964A;MSC2032964A
|
|
1124381-43-6 |
|
Cadazolid；ACT-179811
|
|
1025097-10-2 |
|
Bufotalin；Bufotaline
|
|
471-95-4 |
|
Trierucin
|
|
2752-99-0 |
|
Leptoside
|
|
465-68-9 |
|
BMS-986176
|
|
1815613-42-3 |
|
MFCD28987368
|
|
1610413-97-2 |
|
Ralinepag；APD811
|
|
1187856-49-0 |
|
COH29；RNR Inhibitor COH29
|
|
1190932-38-7 |
|
HAMNO；NSC111847
|
|
138736-73-9 |
|
LDN-193189 2HCl；DM-3189 2HCl
|
|
1435934-00-1 |
|
GSK2983559 active metabolite；RIPK2 inhibitor 1;RIPK2-IN-1;GSK2983559
|
|
1423186-80-4 |
|
SZL P1-41
|
|
222716-34-9 |
|
Acumapimod；BCT-197
|
|
836683-15-9 |
|
BFH772；BFH-722
|
|
890128-81-1 |
|
CBL0137 hydrochloride；CBLC137;CBL0137;Curaxin-137 hydrochloride;CBL-C137 hydrochloride;Curaxin 137
|
|
1197397-89-9 |
|
NSC23005 Sodium
|
|
1796596-46-7 |
|
Azido-PEG12-t-butyl ester
|
|
1818294-45-9 |
|
Futibatinib；FGFR-IN-1;TAS120
|
|
1448169-71-8 |
|
β-Gentiobiose
|
|
554-91-6 |
|
25(S)-Ruscogenin-1-O-α-L-rhamnopyranosyl (1→2)-β-D-xylopyranoside；(1beta,3beta,25S)-3-Hydroxyspirost-5-en-1-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-xylopyranoside
|
|
125225-63-0 |
|
Rotundatin
|
|
144506-16-1 |
|
Avacopan；CCX168
|
|
1346623-17-3 |
|
Exeporfinium chloride；XF 73;XF73;XF-73
|
|
718638-68-7 |
|
Axelopran；TD-1211;TD1211;TD 1211
|
|
949904-48-7 |
|
PNU-200579；PNU 200579;PNU200579
|
|
194482-44-5 |
|
GJ103
|
|
1459687-89-8 |
|
S1p receptor agonist 1；S1p-receptor-agonist-1
|
|
1514888-56-2 |
|
GSK-872；GSK2399872A;GSK'872;GSK872
|
|
1346546-69-7 |
|
Roblitinib；FGF-401
|
|
1708971-55-4 |
|
VA5 TG2 inhibitor；VA-5;VA 5;VA5
|
|
2088001-24-3 |
|
Lys05；Lys01 trihydrochloride
|
|
1391426-24-6 |
|
Pimodivir；VX-787
|
|
1629869-44-8 |
|
Leptine I, from Solanum chacoense；Leptine I
|
|
101030-83-5 |
|
Yadanzioside K
|
|
101559-98-2 |
|
Nanterinone mesylate；UK61260;UK 61260;UK-61260
|
|
102791-74-2 |
|
Monoethyl itaconate
|
|
57718-07-7 |
|
Dobutamine lactobionate
|
|
104564-71-8 |
|
Lanost-7,9(11)-diene-3,24,25-triol-, (3beta,24S)-
|
|
107900-79-8 |
|
Clodronic acid disodium salt；Loron;Lodronate;Clodronate Disodium
|
|
22560-50-5 |
|
AT 4930；AT4930;AT-4930
|
|
123016-40-0 |
|
m-Anisidine, 4-(heptyloxy)-
|
|
15382-63-5 |
|
Polyporusterone B；(1R,2R,4S,5R,7R,11R,14S,15R)-14-[(2R,3R)-2,3-dihydroxy-6-methyl-5-methylideneheptan-2-yl]-4,5,11-trihydroxy-2,15-dimethyltetracyclo[8.7.0.02,?.011,1?]heptadec-9-en-8-one
|
|
141360-89-6 |
|
Schisantherin B；Schizantherin-B;Wuweizi ester-B;Gomisin-B
|
|
58546-55-7 |
